CISG News Alert Cninsure Inc (CISG) 7.11 12/13/2014 02:26:08

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cninsure Inc (CISG) 7.11 $CISG

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 12, 11:46AM CST

ESL: 103.63 (-13.90), CGA: 1.40 (-0.28), FRO: 2.25 (+0.62), RTK: 1.13 (-0.10), TLM: 4.29 (+0.60), MILL: 1.24 (unch), ZQK: 1.91 (+0.43), EOX: 0.97 (-0.31), HGSH: 4.48 (+1.42), ISIG: 3.60 (+0.55), DRL: 3.75 (+0.20), EROC: 2.21 (-0.25), SSTK: 62.51 (-9.16), CISG: 7.11 (+0.85), SOFO: 7.74 (-2.37), CELP: 16.25 (-0.64), CCXI: 5.60 (+1.11), MPO: 1.07 (-0.23), NAO: 11.14 (+1.44), VNR: 15.22 (-1.63)

CNinsure to Expand New Share Issue to Employees
GlobeNewswire - Fri Dec 12, 4:34AM CST
CNinsure Inc. ("CNinsure" or the "Company" (Nasdaq:CISG), a leading independent insurance intermediary company in China, today announced that it has obtained approval from the Board of Directors to increase the new share issue to employees from up to 100,000,000 ordinary shares to 150,000,000 ordinary shares, representing approximately 15% of the Company's current total outstanding share capital. The purchase price for the 100,000,000 ordinary shares is $0.27 per ordinary share or $5.4 per ADS, while that for the additional 50,000,000 ordinary shares is $0.29 per ordinary share or $5.8 per ADS, both of which are the average closing prices for the 20 trading days prior to the board approvals. Completion of the share issuances to the employees is subject to customary closing conditions.
CISG: 7.11 (+0.85)

CNinsure Has More Cash Than Its Market Cap And Double-Digit Revenue Growth
Edward Vranic, CFA - at Seeking Alpha - Mon Dec 01, 10:39AM CST

CISG: 7.11 (+0.85)

Clarification of CNinsure's Announcement to Issue New Shares to Employees
GlobeNewswire - Thu Nov 27, 10:51PM CST
CNinsure Inc. ("CNinsure" or the "Company" (Nasdaq:CISG), a leading independent insurance intermediary company in China, today announced that it has entered into share purchase agreements with companies established on behalf of the employees of the Company (the "Employee Companies" for the issuance of up to 100,000,000 ordinary shares of the Company, representing approximately 10% of the Company's current total outstanding share capital, for a purchase price of $0.27 per ordinary share or $5.4 per ADS, which is the average closing price for the 20 trading days prior to the board approval on November 27, 2014. The shares purchased by the Employee Companies are subject to a 6-month lock-up. Completion of the share issuance to the Employee Companies is subject to customary closing conditions. The Company expects to use the proceeds from the share issuance for working capital and general corporate purposes.
CISG: 7.11 (+0.85)

CNinsure to Issue New Shares to Employees
GlobeNewswire - Thu Nov 27, 4:24AM CST
CNinsure Inc. ("CNinsure" or the "Company" (Nasdaq:CISG), a leading independent insurance intermediary company in China, today announced that it has entered into share purchase agreements with companies established on behalf of the employees of the Company (the "Employee Companies" for the issuance of up to 100,000,000 ordinary shares of the Company, representing approximately 10% of the Company's current total outstanding share capital, for a per share purchase price of $0.27. The Company's shares purchased by the Employee Companies are subject to a 6 months' lock-up period. Completion of the share issuance to the Employee Companies is subject to customary closing conditions. The Company expects to use the proceeds from the share issuance for working capital and general corporate purposes.
CISG: 7.11 (+0.85)

CNinsure's (CISG) CEO Chunlin Wang on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 26, 10:20AM CST

CISG: 7.11 (+0.85)

Cninsure Q3 Earnings Beat on Strong Segmental Performance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 8:30AM CST
Cninsure Inc. (CISG) posted net income of 11 cents per share in the third quarter of 2014, which significantly surpassed the Zacks Consensus Estimate
BRO: 31.92 (-0.52), WSH: 42.91 (-0.59), ERIE: 90.79 (-1.26), CISG: 7.11 (+0.85)

CNinsure (CISG) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 25, 6:55PM CST

CISG: 7.11 (+0.85)

CNinsure reports Q3 profit
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 3:33PM CST

CISG: 7.11 (+0.85)

CNinsure Reports Third Quarter 2014 Unaudited Financial Results
GlobeNewswire - Tue Nov 25, 3:00PM CST
CNinsure Inc, (Nasdaq:CISG), (the "Company" or "CNinsure" , a leading independent insurance intermediary company operating in China, today announced its unaudited financial results for the third quarter ended September 30, 2014.
CISG: 7.11 (+0.85)

CNinsure Down 12.6% Since SmarTrend Downtrend Call (CISG)
Comtex SmarTrend(R) - Tue Nov 18, 9:28AM CST
SmarTrend identified a Downtrend for CNinsure (NASDAQ:CISG) on September 30th, 2014 at $5.73. In approximately 2 months, CNinsure has returned 12.57% as of today's recent price of $5.01.
CISG: 7.11 (+0.85)

CNinsure to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 25, 2014
GlobeNewswire - Wed Nov 05, 12:52AM CST
CNinsure Inc. (Nasdaq:CISG), a leading independent insurance intermediary company operating in China, today announced that it will release its financial results for the third quarter 2014 after the close of the U.S. financial markets on November 25, 2014.
CISG: 7.11 (+0.85)

CNinsure to Present at Morgan Stanley 13th Annual Asia Pacific Summit in Singapore
GlobeNewswire - Mon Nov 03, 2:33AM CST
CNinsure Inc. (Nasdaq:CISG), (the "Company" or "CNinsure" , a leading independent insurance intermediary company operating in China, today announced that its chief financial officer, Mr. Peng Ge, will participate in the Morgan Stanley 13th Annual Asia Pacific Summit in Singapore on 14 November, 2014. The schedule is subject to change.
CISG: 7.11 (+0.85), MS: 36.25 (-1.15)

CNinsure's Online Mutual Aid Platform Members Topped 167,000
GlobeNewswire - Thu Oct 16, 10:30AM CDT
CNinsure Inc. (Nasdaq:CISG), a leading independent insurance intermediary company operating in China, today announced that the number of paid members of eHuzhu, an online mutual aid platform launched by CNinsure, has surpassed 167,000, a threshold that guarantees the capped financial aid of RMB500,000 provided to a member diagnosed with cancer, or the family of a member who died accidentally.
CISG: 7.11 (+0.85)

CNinsure to Host Its O2O Strategy Day in Hong Kong on October 21, 2014
GlobeNewswire - Wed Oct 08, 9:21PM CDT
CNinsure Inc. (Nasdaq:CISG), a leading independent insurance intermediary company operating in China, today announced it will host its O2O Strategy Day at Hennessy Room, Level 7, Conrad Hong Kong, Pacific Place, 88 Queensway, Hong Kong on Tuesday, October 21, 2014 from 9:30 a.m. to approximately 12:00 p.m. Beijing/Hong Kong time. The event will feature presentations by Chairman, Mr. Yinan Hu; Chief Executive Officer, Mr. Chunlin Wang; and Chief Financial Officer, Mr. Peng Ge, on its strategies to become a leading O2O insurance sales and services platform in China, and will include a question and answer section. Management in charge of online projects will also be present.
CISG: 7.11 (+0.85)

GVI, BSV, PWZ, CISG, SSN, AGZ Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Sep 30, 3:33AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares Barclays Intermediate Govt/Credit Bd Fd (NYSE:GVI), Vanguard Short-Term Bond ETF (NYSE:BSV), Powershares Exchange-Traded Fund Trust II (NYSE WZ), CNinsure Inc (NASDAQ:CISG), Samson Oil and Gas Ltd (NYSE:SSN), iShares Barclays Agency Bond Fund (NYSE:AGZ) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BSV: 80.30 (+0.17), GVI: 111.18 (+0.43), SSN: 0.19 (-0.01), PWZ: 25.76 (+0.02), AGZ: 113.31 (+0.21), CISG: 7.11 (+0.85)

Brown & Brown Prices $500M Notes, Moody's Rates Baa3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 2:40PM CDT
Brown & Brown (BRO) offered 4.2% 10-year senior notes worth $500 million. Moody's assigned a Baa3 rating with stable outlook.
BRO: 31.92 (-0.52), ERIE: 90.79 (-1.26), CISG: 7.11 (+0.85), MCO: 93.47 (-2.70)

How the World’s Biggest Bank Helps Investors Understand China
at The Street - Fri Aug 29, 12:46PM CDT
A first-half financial report tells of ICBC’s higher earnings as well as growth areas backed by the bank, such as the Chinese service sector and automakers in Africa
F: 14.99 (-0.29), LFC: 50.74 (-1.28), DANG: 9.28 (unch), JD: 23.97 (-0.82), CISG: 7.11 (+0.85)

China Stock Roundup: Sinopec 1H14 Net Income Up, Qihoo 360 Misses - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Aug 28, 11:57AM CDT
Stocks suffered a disappointing week following the commencement of 10 new IPOs this week.
QIHU: 60.22 (+0.32), YGE: 2.27 (-0.03), SNP: 76.12 (-1.62), TSL: 8.82 (-0.30), AAPL: 109.73 (-1.89), CISG: 7.11 (+0.85)

Cninsure Beats Q2 Earnings on Solid Segmental Performance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 9:00AM CDT
Cninsure Inc. (CISG) posted second quarter 2014 net income of 18 cents per share, surpassing the Zacks Consensus Estimate by 80%.
VR: 40.85 (-0.48), BRO: 31.92 (-0.52), AON: 95.01 (-1.28), CISG: 7.11 (+0.85)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 257

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 85

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 52

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 110

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

DESRI Completes Major Financing for Texas Solar Projects

Updated Category News Views 324

DESRI Completes Major Financing for Texas Solar Projects Today, DESRI proudly announced that it has closed a significant preferred equity financing of $129 million aimed at a 250-megawatt (MWac) solar development portfolio. This portfolio consists of two innovative solar projects located in West Texas, an area ripe for renewable energy enhancement. Meeting Industrial...

Continue Reading
Colossal Foundation Invests $500,000 in Condor Restoration Efforts

Updated Category News Views 76

Colossal Foundation Invests in Wildlife Recovery The Colossal Foundation has made a significant commitment of $500,000 towards restoring the California condor to its ancestral skies. This incredible movement represents a decade-long partnership with the Nez Perce Tribe, focusing on the recovery and reintroduction of North America’s largest land bird. For more than a...

Continue Reading
Revolutionary Self-Healing Film: The Future of Waterproofing

Updated Category News Views 108

Revolutionary Waterproofing Solutions by Charter Next Generation Charter Next Generation (CNG) recently unveiled its groundbreaking Nail Sealable film technology, designed to transform waterproofing in the construction industry. This pioneering self-healing film stands out with its exceptional moisture resistance and remarkable durability, making it a game changer for...

Continue Reading
Sonnet BioTherapeutics Provides Positive Safety Insights on SON-1010

Updated Category News Views 273

Exciting Safety Data from Sonnet BioTherapeutics’ SON-1010 Trial Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) has unveiled impressive topline safety data following a successful dose escalation of SON-1010 in the Phase 1 SB101 clinical trial. The study focused on the administration of SON-1010 to patients suffering from advanced solid tumors, marking a significant...

Continue Reading
Key Legal Information for Symbotic Inc. Shareholders

Updated Category News Views 73

Important Information for Symbotic Inc. Investors Recent developments surrounding Symbotic Inc. have captured the attention of investors globally. Investors who are shareholders of Symbotic Inc. (NASDAQ: SYM) may need to be aware of significant deadlines regarding a recent securities class action lawsuit. Overview of the Lawsuit Investors are reminded that they may have...

Continue Reading